Metabolomics Reveals a “Trimeric” γ‐Actinorhodin from Streptomyces coelicolor M145

Abstract

AbstractStreptomyces coelicolor is a prolific producer of natural products and serves as a model organism for their study. It produces several pigmented antibiotics, the best‐studied of which are the actinorhodins. We used a combination of liquid chromatography‐mass spectrometry (LC–MS) and computational tools used for annotating the detected species (e. g., spectral matching, in‐silico predictors, molecular networking) to identify putative new actinorhodin analogs. These studies led to the discovery of the first trimeric benzoisochromanequinone, θ‐actinorhodin (1). Further metabolomics analysis revealed that the relative amounts of shunt products produced were similar between the two growth conditions explored. This suggests that, while substantially different products were being produced, the biosynthetic gene clusters were similarly active. Overall, this work describes the discovery of the first trimeric benzoisochromanequinone and explores the biosynthetic processes that might lead to its production by metabolomics analysis of relevant intermediates.